Connecting

NES Global Talent Acquires California-based Life Science Consulting Firm – Redbock LLC.

June 15, 2018
redbock-logo

NES is pleased to announce it has acquired Redbock LLC (Redbock) - a highly regarded consultancy that delivers expertise to the pharmaceutical, biotechnology and medical devices industries.

Redbock is a well-established provider of consulting solutions in the Life Science industry. With a strong brand reputation, Redbock is built on strong business practices and reliable execution.

The combination of NES’s global reach and Redbock’s local expertise further strengthens NES’s position as the partner of choice for Life Science consulting solutions across the world.

Tig Gilliam, CEO, NES Global Talent comments:

“We are very pleased to welcome Redbock to the NES team. NES Global Talent continues to complement our organic growth approach with strategic acquisitions that fit our business. We were delighted to find this opportunity with Redbock. Our business is a people business, and we are very pleased to join with a team that shares our core values. This combination will further strengthen and accelerate our Life Sciences capabilities and continue to build on our vision to be a world leader in delivering highly qualified professionals to critical industries around the world.”

David Hnatek, CEO, Redbock added:

“Redbock was created to deliver superior talent to the pharmaceutical, biotechnology and medical devices industries, and I am extremely proud of the success we have had since our inception. NES Global Talent is one of the most respected staffing companies in the world and joining with them will bring proven capabilities and a global infrastructure, which we believe will help to deliver additional resources and fantastic support to both our customers and candidates.”

Due to the strong business and brand reputation Redbock holds, NES advised that there will be no immediate changes to operations. Both businesses will continue to operate without disruption to customers or contractors.

Fairmount Partners acted as the investment bank for Redbock and its owners. The Fairmount Pharmaceutical Services team has completed 126 transactions in 18 countries in North and South America, Europe, Asia and Australia.